Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target.

MLA

Xu, Chao, et al. “Predicting Hepatocellular Carcinoma Outcomes and Immune Therapy Response with ATP-Dependent Chromatin Remodeling-Related Genes, Highlighting MORF4L1 as a Promising Target.” Cancer Cell International, vol. 25, no. 1, Jan. 2025, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12935-024-03629-2.

APA

Xu, C., Liang, L., Liu, G., Feng, Y., Xu, B., Zhu, D., Jia, W., Wang, J., Zhao, W., Ling, X., Zhou, Y., Ding, W., & Kong, L. (2025). Predicting hepatocellular carcinoma outcomes and immune therapy response with ATP-dependent chromatin remodeling-related genes, highlighting MORF4L1 as a promising target. Cancer Cell International, 25(1), 1–17. https://doi.org/10.1186/s12935-024-03629-2

Chicago

Xu, Chao, Litao Liang, Guoqing Liu, Yanzhi Feng, Bin Xu, Deming Zhu, Wenbo Jia, et al. 2025. “Predicting Hepatocellular Carcinoma Outcomes and Immune Therapy Response with ATP-Dependent Chromatin Remodeling-Related Genes, Highlighting MORF4L1 as a Promising Target.” Cancer Cell International 25 (1): 1–17. doi:10.1186/s12935-024-03629-2.